These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5050735)

  • 1. Studies on the episodic secretion of cortisol in uremic patients on hemodialysis.
    Mishkin MS; Hsu TH; Walker G; Bledsoe T
    Johns Hopkins Med J; 1972 Aug; 131(2):160-4. PubMed ID: 5050735
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
    Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
    Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol is secreted episodically by normal man.
    Hellman L; Nakada F; Curti J; Weitzman ED; Kream J; Roffwarg H; Ellman S; Fukushima DK; Gallagher TF
    J Clin Endocrinol Metab; 1970 Apr; 30(4):411-22. PubMed ID: 4314077
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged serum half-life of cortisol in renal failure.
    Bacon GE; Kenny FM; Murdaugh HV; Richards C
    Johns Hopkins Med J; 1973 Feb; 132(2):127-31. PubMed ID: 4684170
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum calcium in dialyzed uremic patients.
    Danesh BJ; Walker CH; Mathers NP
    N Engl J Med; 1970 Jul; 283(3):155-6. PubMed ID: 5423156
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
    Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
    [No Abstract]   [Full Text] [Related]  

  • 9. [The nature of renal lesions and periodic hemodialysis].
    Bonomini V; Mioli V; Albertazzi A; Vangelista A
    Minerva Nefrol; 1972; 19(2):50-9. PubMed ID: 4681261
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum calcium in dialyzed uremic patients.
    Hattner RS; Jacobs J; Bernstein DS
    N Engl J Med; 1970 Jul; 283(3):155. PubMed ID: 5423155
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone immunoreactivity in the plasma filtrate of uremic patients.
    Tsutsumi M; Fukase M; Fujita T; Fujita K; Inoue S; Shin J
    Miner Electrolyte Metab; 1982 Mar; 7(3):146-50. PubMed ID: 7169980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of cephaloridine and cephalothin in patients with renal impairment.
    Kunin CM; Atuk N
    N Engl J Med; 1966 Mar; 274(12):654-6. PubMed ID: 17926378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exercise on the secretion and metabolism of cortisol in man.
    Few JD
    J Endocrinol; 1974 Aug; 62(2):341-53. PubMed ID: 4413053
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperthyroidism and cortisol secretion in man.
    Gallagher TF; Hellman L; Finkelstein J; Yoshida K; Weitzman ED; Roffwarg HD; Fukushima DK
    J Clin Endocrinol Metab; 1972 Jun; 34(6):919-27. PubMed ID: 5020423
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphate in uremic patients during and between hemodialysis.
    Hillion D; Haas T
    Clin Nephrol; 1994 Oct; 42(4):275. PubMed ID: 7695753
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H; Bergström J; Fürst P; Johnson C; Yahiel V
    Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis of doxepin and desmethyldoxepin in uremic patients.
    Faulkner RD; Senekjian HO; Lee CS
    Artif Organs; 1984 May; 8(2):151-5. PubMed ID: 6732542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derangement of acid-base balance in uremia and under hemodialysis.
    Messa P; Mioni G; Maio GD; Ferrando C; Lamperi D; Famularo A; Paoletti E; Cannella G
    J Nephrol; 2001; 14 Suppl 4():S12-21. PubMed ID: 11798141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a 1100-1300 MW uremic neurotoxin.
    Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
    Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.